VIA

Virtus Investment Advisers Portfolio holdings

AUM $349M
1-Year Est. Return 25.41%
This Quarter Est. Return
1 Year Est. Return
+25.41%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$296M
AUM Growth
-$72M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
512
New
Increased
Reduced
Closed

Top Buys

1
+$2.01M
2
+$1.82M
3
+$1.75M
4
CSCO icon
Cisco
CSCO
+$1.7M
5
STT icon
State Street
STT
+$1.69M

Top Sells

1
+$32.2M
2
+$24.6M
3
+$19M
4
SMC
Summit Midstream
SMC
+$3.67M
5
JNK icon
State Street SPDR Bloomberg High Yield Bond ETF
JNK
+$2.09M

Sector Composition

1 Financials 33.24%
2 Healthcare 17.43%
3 Technology 12.41%
4 Industrials 9.1%
5 Consumer Discretionary 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RNAC icon
351
Cartesian Therapeutics
RNAC
$191M
$95.4K 0.03%
9,183
+1,023
TNGX icon
352
Tango Therapeutics
TNGX
$1.57B
$95.3K 0.03%
18,620
-38,979
SVRA icon
353
Savara
SVRA
$1.2B
$94.9K 0.03%
41,607
-7,399
IRON icon
354
Disc Medicine
IRON
$2.71B
$94.5K 0.03%
1,784
-772
IMVT icon
355
Immunovant
IMVT
$5.24B
$94.4K 0.03%
5,899
-54
RLAY icon
356
Relay Therapeutics
RLAY
$1.32B
$94.3K 0.03%
27,256
-7,089
CLDX icon
357
Celldex Therapeutics
CLDX
$1.71B
$94K 0.03%
4,621
-1,587
ITOS
358
DELISTED
iTeos Therapeutics
ITOS
$93.9K 0.03%
9,422
-11,241
AKRO
359
DELISTED
Akero Therapeutics
AKRO
$93.7K 0.03%
1,756
-3,898
CYTK icon
360
Cytokinetics
CYTK
$7.76B
$93.6K 0.03%
2,832
-438
COGT icon
361
Cogent Biosciences
COGT
$6B
$93.5K 0.03%
13,024
-6,663
LENZ
362
LENZ Therapeutics
LENZ
$567M
$93.2K 0.03%
3,179
-2,155
ACLX icon
363
Arcellx
ACLX
$3.95B
$93.1K 0.03%
1,414
-554
PTGX icon
364
Protagonist Therapeutics
PTGX
$5.29B
$92.3K 0.03%
1,670
-2,395
CGON icon
365
CG Oncology
CGON
$4.27B
$92.2K 0.03%
3,548
-2,138
NUVL icon
366
Nuvalent
NUVL
$8.25B
$92.1K 0.03%
1,207
-683
KROS icon
367
Keros Therapeutics
KROS
$586M
$92K 0.03%
6,894
-2,013
RXRX icon
368
Recursion Pharmaceuticals
RXRX
$2.43B
$92K 0.03%
18,188
-5,330
BEAM icon
369
Beam Therapeutics
BEAM
$3.25B
$91.7K 0.03%
5,392
-464
MREO
370
Mereo BioPharma
MREO
$107M
$91.7K 0.03%
33,825
-10,182
ARWR icon
371
Arrowhead Research
ARWR
$9.2B
$91.6K 0.03%
5,797
-1,618
ARVN icon
372
Arvinas
ARVN
$779M
$91.4K 0.03%
12,422
+4,104
CVAC
373
DELISTED
CureVac
CVAC
$91.2K 0.03%
16,792
-34,504
DNTH icon
374
Dianthus Therapeutics
DNTH
$1.88B
$90.8K 0.03%
4,875
-2,111
VIR icon
375
Vir Biotechnology
VIR
$864M
$90.8K 0.03%
18,014
-4,079
13 14
15
16 17